These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 5735705

  • 1. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
    Boccitto G, Sbampato M, Sternini N.
    Ann Ist Carlo Forlanini; 1968; 28(2):126-41. PubMed ID: 5735705
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE, Alekseeva VM, Ivanova ES, Kubyshkina VF, Kliuchareva EA.
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
    Grassi C.
    Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
    [No Abstract] [Full Text] [Related]

  • 5. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G.
    Wien Med Wochenschr; 1972 Dec 16; 122(51):764-8. PubMed ID: 4346497
    [No Abstract] [Full Text] [Related]

  • 6. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G.
    Wien Med Wochenschr; 1967 Mar 18; 117(11):266-8. PubMed ID: 5626324
    [No Abstract] [Full Text] [Related]

  • 7. [The role of rifampicin in the treatment of recent tubercular processes].
    Catena E, Del Bono M, Marsico SA.
    Arch Tisiol Mal Appar Respir; 1968 Apr 18; 23(4):329-52. PubMed ID: 5307454
    [No Abstract] [Full Text] [Related]

  • 8. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M.
    Orv Hetil; 1970 Mar 15; 111(11):603-8. PubMed ID: 4911914
    [No Abstract] [Full Text] [Related]

  • 9. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E.
    Dtsch Med Wochenschr; 1970 Jan 16; 95(3):139-41. PubMed ID: 5411222
    [No Abstract] [Full Text] [Related]

  • 10. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
    Celotti A.
    Minerva Med; 1965 Sep 05; 56(71):2892-7. PubMed ID: 5322270
    [No Abstract] [Full Text] [Related]

  • 11. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 Sep 05; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 12. [Advances in the therapy of tuberculosis].
    Corbalán Trumbull G.
    Rev Med Chil; 1970 Jan 05; 98(1):26-30. PubMed ID: 4157372
    [No Abstract] [Full Text] [Related]

  • 13. [Current status of the antitubercular chemotherapy].
    Radenbach KL.
    Internist (Berl); 1973 Mar 05; 14(3):100-10. PubMed ID: 4573242
    [No Abstract] [Full Text] [Related]

  • 14. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1969 Mar 05; 69():43-53. PubMed ID: 4906373
    [No Abstract] [Full Text] [Related]

  • 15. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A, Ciobanu V, Cojocaru G, Borşaru I, Ciobanu D, Spirescu G, Roşianu D, Pescariu M.
    Ftiziologia; 1971 Mar 05; 20(6):623-8. PubMed ID: 5162289
    [No Abstract] [Full Text] [Related]

  • 16. [New drugs in antitubercular therapy].
    Favez G.
    Helv Med Acta Suppl; 1969 Mar 05; 49():66-80. PubMed ID: 4912509
    [No Abstract] [Full Text] [Related]

  • 17. Drugs in the treatment of tuberculosis--1969.
    Beacham EG.
    Johns Hopkins Med J; 1969 Nov 05; 125(5):286-90. PubMed ID: 5366128
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
    Carratù L, Sonaglioni F, Natali P.
    Arch Tisiol Mal Appar Respir; 1968 May 05; 23(5):399-410. PubMed ID: 5306592
    [No Abstract] [Full Text] [Related]

  • 19. [Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
    Mamolat AS, Bialik IB.
    Probl Tuberk; 1979 Nov 05; (11):20-6. PubMed ID: 530963
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF, Sagalovich VIa.
    Probl Tuberk; 1974 Nov 05; (12):26-30. PubMed ID: 4445131
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.